Jiangsu Kanion Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Jiangsu Kanion Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Jiangsu Kanion Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Selling expenses596,226,2590.05599422015-06-30historic
Notes receivable621,349,2180.05835992015-06-30historic
Cash paid for taxes234,348,2950.022012292015-06-30historic
Operating profit222,477,3380.020892592015-06-30historic
Net income191,702,2910.0182642015-06-30historic
Other payables358,972,3100.033712762015-06-30historic
Total profit225,812,3940.02122812015-06-30historic
Total comprehensive income191,701,5440.0182852015-06-30historic
Purchases of fixed assets and others192,985,8030.018123102015-06-30historic
Goodwill58,988,8580.005543322015-06-30historic
Investment income from associate and joint venture2,3500.03842015-06-30historic
Comprehensive income attributable to minority shareholders1,786,3071.7E-44442015-06-30historic
Minority interests gain1,786,3071.7E-44532015-06-30historic
Intangible assets228,672,4530.021475102015-06-30historic
Long term borrowings100,000,0000.009395332015-06-30historic
Financial expenses22,257,0360.002095562015-06-30historic
Fixed assets1,076,559,2720.101095652015-06-30historic
Other receivables57,455,0050.00545702015-06-30historic
Short term borrowings453,868,5380.042625782015-06-30historic
Interests payable1,364,0641.3E-45812015-06-30historic
Revenue1,427,337,2420.134035912015-06-30historic
Cash inflows from operating activities1,454,113,7720.136555972015-06-30historic
Total cost of goods sold1,204,862,2540.113146222015-06-30historic
Minority interest58,936,5910.005536282015-06-30historic
Total non-current assets2,022,960,2610.189966402015-06-30historic
Cash outflows from operating activities1,257,764,7250.118116452015-06-30historic
Non-operating loss950,9459.0E-56502015-06-30historic
Cash paid for dividends, profits or interests58,257,2440.005477022015-06-30historic
Accounts payable282,981,0280.026577432015-06-30historic
Disposal of fixed assets and others75,0001.0E-57522015-06-30historic
Total liabilities1,501,038,7690.140957692015-06-30historic
Total liabilities and equity4,197,561,1790.394177702015-06-30historic
Long term equity investment3,978,6973.7E-48052015-06-30historic
Cash inflows from financing activities363,474,2870.034138172015-06-30historic
Net cash flows from investing activities-192,910,803-0.018128712015-06-30historic
Prepayment43,545,9720.004098762015-06-30historic
Capital reserve520,433,1420.048879722015-06-30historic
Deferred tax assets7,267,7316.8E-410432015-06-30historic
Net cash and cash equivalents ending balance236,389,6980.022210672015-06-30historic
Inventories144,617,3420.0135810982015-06-30historic
Net change in cash-317,152,521-0.0297811612015-06-30historic
Payroll payable3,661,2853.4E-412002015-06-30historic
Net cashflow from financing activities-320,589,682-0.030112082015-06-30historic
Diluted eps00.012772015-06-30historic